Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics
Biology · 23.07.2024 · 13 (8) · 555
DOI: 10.3390/biology13080555 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 23.07.2024. Verfasst von Mingjie Zou und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center, Medical School of Nanjing University, Nanjing 2100…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Throughout the human lifespan, from conception to the end of life, small molecules have an intrinsic relationship with numerous physiological processes. The investigation into small-molecule targets holds significant implications for pharmacological discovery. The determination of the action sites of small molecules provide clarity into the pharmacodynamics and toxicological mechanisms of small-molecule drugs, assisting in the elucidation of drug off-target effects and resistance mechanisms. Consequently, innovative methods to study small-molecule targets have proliferated in recent years, with chemical proteomics standing out as a vanguard development in chemical biology in the post-genomic age. Chemical proteomics can non-selectively identify unknown targets of compounds within complex biological matrices, with both probe and non-probe modalities enabling effective target identification. This review attempts to summarize methods and illustrative examples of small-molecule target identification via chemical proteomics. It delves deeply into the interactions between small molecules and human biology to provide pivotal directions and strategies for the discovery and comprehension of novel pharmaceuticals, as well as to improve the evaluation of drug safety.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center, Medical School of Nanjing University, Nanjing 210093, China.
ORCID-Profile: Haiyuan Zhou
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Zou, M., Zhou, H., Gu, L., Zhang, J., & Fang, L. (2024). Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics. Biology, 13(8), 555. https://doi.org/10.3390/biology13080555
Vancouver
Zou M, Zhou H, Gu L, Zhang J, Fang L. Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics. Biology. 2024;13(8):555. doi:10.3390/biology13080555
BibTeX
@article{Zou2024,
author = {Zou, Mingjie and Zhou, Haiyuan and Gu, Letian and Zhang, Jingzi and Fang, Lei},
title = {Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics},
journal = {Biology},
year = {2024},
volume = {13},
number = {8},
pages = {555},
doi = {10.3390/biology13080555}
}
EUVIMED